Niflumic acid, 2-{[3-(trifluoromethyl)phenyl]amino}pyridine-3-carboxylic acid (NFA), is a nonsteroidal anti-inflammatory drug that also blocks or modifies the gating of many ion channels. Here, we investigated the effects of NFA on hyperpolarization-activated cyclic nucleotide-gated cation (HCN) pacemaker channels expressed in X. laevis oocytes using site-directed mutagenesis and the two-electrode voltageclamp technique. Extracellular NFA acted rapidly and caused a slowing of activation and deactivation and a hyperpolarizing shift in the voltage dependence of HCN2 channel activation (Ϫ24.5 Ϯ 1.2 mV at 1 mM). Slowed channel gating and reduction of current magnitude was marked in oocytes treated with NFA, while clamped at 0 mV but minimal in oocytes clamped at Ϫ100 mV, indicating the drug preferentially interacts with channels in the closed state. NFA at 0.1 to 3 mM shifted the half-point for channel activation in a concentration-dependent manner, with an EC 50 of 0.54 Ϯ 0.068 mM and a predicted maximum shift of Ϫ38 mV. NFA at 1 mM also reduced maximum HCN2 conductance by ϳ20%, presumably by direct block of the pore. The rapid onset and state-dependence of NFA-induced changes in channel gating suggests an interaction with the extracellular region of the S4 transmembrane helix, the primary voltage-sensing domain of HCN2. Neutralization (by mutation to Gln) of any three of the outer four basic charged residues in S4, but not single mutations, abrogated the NFAinduced shift in channel activation. We conclude that NFA alters HCN2 gating by interacting with the extracellular end of the S4 voltage sensor domains.
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Niflumic acid (NFA) and other fenamates (e.g., flufenamic acid, mefenamic acid, meclofenamic acid) inhibit type 2 cyclooxygenase and are used as anti-inflammatory drugs to relieve acute pain and to treat rheumatoid arthritis. NFA has many other activities that are unrelated to its intended pharmacology. For example, NFA blocks or potentiates the effects of GABA on GABA A receptors in a subunit-dependent manner (Sinkkonen et al., 2003) , inhibits gap junction hemichannels (Eskandari et al., 2002) , and affects the gating of many types of ion channels. NFA and other fenamates were first demonstrated to block Cl Ϫ channels (White and Aylwin, 1990; Scott-Ward et al., 2004) , but these compounds also block Kv2.1 channels (Lee and Wang, 1999) , activate large conductance Ca 2ϩ -activated (Ottolia and Toro, 1994 ) and hERG1 (Malykhina et al., 2002) K ϩ channels, and alter the voltage dependence of gating of Kv4.2, Kv4.3 (Wang et al., 1997) , KCNQ1/minK (Busch et al., 1994) , KCNQ2/3 (Peretz et al., 2005) , and HCN pacemaker (Accili and DiFrancesco, 1996; Satoh and Yamada, 2001 ) channels. For all channel types, the onset of NFA activity is very rapid, consistent with its binding to a site readily accessible from the extracellular side of the membrane. The three-dimensional structure of a complex formed between NFA and a receptor has only been determined for the enzyme phospholipase A2. In this case, NFA inhibits phospholipase A2 by interaction with the substrate binding site via the active-site residues His48 and Asp49 (Jabeen et al., 2005) .
The effects of NFA on pacemaker current (i f in heart or i h in neurons) have been previously studied in cardiac myocytes (Accili and DiFrancesco, 1996) and in photoreceptors (Satoh and Yamada, 2001 ). Accili and DiFrancesco (1996) reported that NFA at 50 and 500 M slows the pacing rate of rabbit sinoatrial node myocytes by slowing the kinetics of i f and shifting its voltage dependence of activation to more negative potentials, without causing a change in slope conductance or ion selectivity. In newt rod photoreceptors, Satoh and Yamada (2001) reported that NFA at 100 M slowed the activation and deactivation of i h and reduced the steady-state current in a voltage-dependent manner, effects explained by a negative shift in the voltage dependence of channel activation. Similar to i f in myocytes, the fully activated conductance of i h in photoreceptors was not affected by 100 M NFA. When applied to the bath solution, NFA did not affect pacemaker currents measured in excised inside-out patches of sinoatrial node myocytes (Accili and DiFrancesco, 1996) or rod photoreceptors (Satoh and Yamada, 2001) , indicating that the drug binds to the extracellular side of the channel. Thus, NFA slows the rate of activation and decreases the amplitude of pacemaker current by affecting channel gating in native cells. However, the fenamate binding site has not been identified at the molecular level for pacemaker or any other type of ion channel.
Here, we characterize the mechanisms of action of NFA on cloned mammalian HCN2 channels heterologously expressed in Xenopus laevis oocytes. We test the hypothesis that NFA alters HCN2 channel gating by interacting with the basic residues located in the extracellular end of the S4 transmembrane domain, the main component of the voltage sensor.
Materials and Methods
Molecular Biology. mHCN2 cDNA was cloned from MarathonReady (Clontech, Mountain View, CA) mouse brain cDNA and inserted into the pSP64T oocyte expression vector as previously described (Chen et al., 2000) . Mutations were introduced into N-terminal truncated mouse HCN2 (HCN2 ntk ) cDNA as described previously (Chen et al., 2000) . Restriction mapping and DNA sequencing of the polymerase chain reaction-amplified segment were used to confirm the presence of the desired mutation and the lack of extra mutations. cRNA for injection into oocytes was prepared with SP6 Capscribe (Roche, Indianapolis, IN) after linearization with EcoRI. RNA quality was checked by gel electrophoresis, and concen- Fig. 1 . NFA slows the rate of onset of WT HCN2 current activation and shifts its voltage dependence of activation to more negative potentials. A and B, WT HCN2 channel currents recorded from a single oocyte during 5-s pulses to test potentials ranging from Ϫ10 to Ϫ130 mV, applied in 10-mV steps. The V h was Ϫ30 mV, recorded at a V t of Ϫ90 mV (C) and Ϫ120 mV (D). Traces recorded before (control) and after exposure to 1 mM NFA are superimposed. At Ϫ90 mV, control: f ϭ 489 ms, s ϭ 2400 ms; A f /(A f ϩ A s ) ϭ 0.64; 1 mM NFA: ϭ 3239 ms. At Ϫ120 mV, control: f ϭ 140 ms, s ϭ 448 ms; A f /(A f ϩ A s ) ϭ 0.96; 1 mM NFA: f ϭ 258 ms, s ϭ 1271 ms; A f /(A f ϩ A s ) ϭ 0.65. E, I-V relationship measured before and after NFA. Currents were measured at the end of the 5-s pulse to the indicated V t . F, effect of NFA on the voltage dependence of current activation. Currents were not corrected for instantaneous leak. Under control conditions the V 1/2 was Ϫ69 mV (k ϭ 7.1 mV); after 1 mM NFA, V 1/2 was Ϫ96 mV and k was 6.5 mV. All data are from the same oocyte.
Niflumic Acid Alters Gating of HCN2

1211
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Voltage Clamp of Oocytes. Isolation and maintenance of X. laevis oocytes and cRNA injections were performed as described previously (Goldin, 1991) . In brief, stage IV and V X. laevis oocytes were injected with 10 to 50 ng of cRNA encoding WT or mutant HCN2 ntk channels. After injection with cRNA, the oocytes were cultured at 18°C for 1 to 3 days in Barth's solution containing 88 mM NaCl, 1 mM KCl, 1 mM MgSO 4 , 0.41 mM CaCl 2 , 2.4 mM NaHCO 3 , 10 mM HEPES, 0.33 mM Ca(NO 3 ) 2 , 50 g/ml gentamycin, and 1 mM pyruvate, pH 7.4. For voltage-clamp experiments, oocytes were bathed in a modified ND96 external solution containing 96 mM NaCl, 4 mM KCl, 1 mM MgCl 2 , 1 mM CaCl 2 , and 5 mM HEPES, pH 7.6. Currents were recorded at room temperature (22-24°C) with a GeneClamp 500 amplifier (Molecular Devices, Sunnyvale, CA) using standard two-microelectrode voltage-clamp techniques (Stü hmer, 1992) . Current-voltage (I-V) relationships for WT and mutant channels were determined using 5-s test pulses applied from a holding potential (V h ) of Ϫ30 mV to test potentials (V t ) ranging from Ϫ130 to Ϫ30 mV. Pulses were applied once every 21 s. For all experiments, the oocyte recording chamber was constantly perfused with external solution at a rate of 2 ml/min. Drug-induced reduction of current was assessed by measuring inward current at the end of a 5-s hyperpolarizing pulse to Ϫ100 mV and calculating percentage reduction based on currents measured before drug and after complete block of HCN2 current with 20 mM CsCl.
To determine whether NFA preferentially affects HCN2 channels in the open or closed state, oocytes were treated with NFA, while the V h was maintained at either 0 mV or Ϫ100 mV. At 0 mV, WT HCN2 channels are closed, whereas at Ϫ100 mV, most channels are in the open state. To assess drug interaction with closed channels, a single 2-s pulse to Ϫ100 mV (followed by a 1-s pulse to ϩ 20 mV to assess deactivation) was applied immediately before addition of NFA to assess current magnitude in the absence of drug. The oocyte was then clamped to 0 mV without pulsing while it was exposed to 1 mM NFA for 3 min. At the end of the 3-min incubation period, a single 2-s pulse to Ϫ100 mV was applied again and compared with the predrug current. To assess drug interaction with open channels, a 3-min pulse to Ϫ100 mV was applied from a V h of 0 mV. After 30 s, the perfusate was switched from the modified ND96 ϩ 1% DMSO (control) solution to one containing 1 mM NFA. The effect of NFA was assessed by comparing current magnitude at 30 s (predrug) versus current at 3 min (with drug).
The structure of NFA (2-{[3-(trifluoromethyl)phenyl]amino}-pyridine-3-carboxylic acid) is shown as an inset in Fig. 1B . NFA was purchased from Sigma-Aldrich (St. Louis, MO) and was prepared as a 100 mM stock solution in DMSO. An aliquot of this stock solution was dissolved in the modified ND96 external solution immediately before use to obtain the final desired drug concentrations. All solutions containing NFA were corrected to pH 7.6 with NaOH. The control solution always contained the same amount of DMSO as the NFA solution (e.g., 1% DMSO for 1 mM NFA).
Data Analysis. The fast and slow time constants for HCN2 current activation ( f , s ) at Ϫ100 mV were determined using the standard exponential curve fitting routine of pClamp 8 software (Molecular Devices). Time-dependent activating currents (I act ) were fitted with a two-exponential function: I act (t) ϭ A f e Ϫt/f ϩ A s e Ϫt/f ϩ C. The time constants for deactivation ( deact ) were determined at ϩ20 mV after a test pulse to Ϫ130 mV. The effect of NFA on the voltage dependence of WT or HCN ntk channels was determined using 5-s pulses to a wide range of V t . For WT channels, V t ranged from Ϫ130 to Ϫ10 mV, but for some mutant channels, V t was varied from Ϫ160 to Ϫ20 or Ϫ40 mV. Each V t was followed by a second pulse to a potential of Ϫ130 mV (or Ϫ160 mV). The initial current amplitude recorded during the second pulse was corrected for leak, defined as the instantaneous current after a prepulse to Ϫ10 mV. The leak-corrected currents were then plotted as a function of V t , and the relationship was fitted with a Boltzmann function to determine the maximum current value (I max ) under control conditions. All current amplitudes from an individual oocyte were normalized to its own I max , plotted as a function of V t and fitted again with a Boltzmann function (I/I max ϭ 1/[1 ϩ exp((V t Ϫ V 1/2 )/k)]) using Origin 7.5 software (OriginLab Corp., Northampton, MA) to determine the values of the half-point (V 1/2 ) and the slope factor (k) for channel activation.
The shift in V 1/2 (⌬V 1/2 , in mV) was plotted as a function of [NFA] , and the data were fit to a dose-response logistic function (
nH }) using Origin 7.5, where V max is the maximal shift in V 1/2 , EC 50 is the drug concentration required for 50% of the maximum shift in V 1/2 , and n H is the Hill coefficient.
Data are presented as mean Ϯ S.E. (n ϭ number of oocytes), and statistical comparisons between experimental groups were per- Fig. 2 . State-dependent modification of WT HCN2 channels by NFA. A, test for effects of NFA on closed channels. Top, voltage pulse protocol and timing of NFA exposure. A test pulse was applied before NFA, and once again after 3 min application of 1 mM NFA. The V h was 0 mV between test pulses. Lower panel shows the two test currents on an expanded time scale. Current activation was elicited with a 2-s pulse to Ϫ100 mV followed by a 1-s pulse to ϩ20 mV to induce deactivation. Current magnitude was defined as time-dependent inward current measured at the end of pulse (indicated by arrows) minus the instantaneous current at start of pulse. B, test for effects of NFA on open channels. Top, voltage pulse protocol. Bottom, inward current at a V h of Ϫ100 mV, the times where current magnitude was measured (indicated by arrows) and the timing of NFA exposure. C, reduction of HCN2 current by NFA, defined as percentage of time-dependent current measured at Ϫ100 mV after 3 min of drug compared with current measured before drug exposure.
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Results
NFA Reduces the Amplitude and Slows Kinetics of HCN2 Channel Currents.
We first determined the effects of 1 mM NFA on currents conducted by WT HCN2 channels expressed in X. laevis oocytes. Currents were elicited with 5-s pulses applied to V t ranging from Ϫ10 to Ϫ130 mV. After each test pulse, the membrane potential was pulsed to Ϫ130 mV for 3 s (Fig. 1A) . NFA slowed the rate of current activation and reduced current amplitude at all test potentials (Fig.  1B ), but the reduction was more pronounced at Ϫ90 mV ( Fig.  1C ) than at Ϫ120 mV (Fig. 1D) . The voltage dependent suppression of current by NFA is readily apparent in the I-V plot ( Fig. 1E ) and was caused by both a reduction in maximum conductance and a shift of the voltage dependence of activation to more negative potentials (Fig. 1F) .
Similar results were obtained in seven oocytes, where the V 1/2 for activation was shifted by an average of Ϫ30.4 mV by 1 mM NFA.
As described under Materials and Methods, two pulse protocols were used to determine whether the effects of NFA on WT HCN2 channels were state-dependent. Modification of channels in the closed state was assessed by treating oocytes with 1 mM NFA while maintaining V h at 0 mV. Test currents were elicited with a 2-s pulse applied to Ϫ100 mV immediately before and after 3-min incubation with NFA ( Fig. 2A) . Interaction of drug with open channels was assessed by switching the perfusate from a drug-free solution to one containing 1 mM NFA 30 s after the start of a 3-min pulse to Ϫ100 mV (Fig. 2B) . The experiments were performed on five oocytes for each pulse protocol and are summarized as a bar plot in Fig. 2C . When channels were maintained in a closed state during treatment with NFA, the current elicited by the second test pulse activated and deactivated slower, and was reduced to 19 Ϯ 3% of the peak inward current measured Fig. 3 . NFA slows the activation rate and shifts the voltage dependence of activation of WT HCN2 ntk channel currents to more negative potentials. A and B, WT HCN2 ntk channel currents recorded from a single oocyte during 5-s pulses to test potentials ranging from Ϫ10 to Ϫ130 mV, applied in 10-mV steps, before (A) and after application of 1 mM NFA(B). The V h was Ϫ30 mV and a pulse to Ϫ130 mV was applied after each test pulse. C, NFA slowed the rate of activation and deactivation of HCN ntk channel current. For control: f ϭ 159 ms, s ϭ 1315 ms;
-V relationship measured before and after NFA. Currents were measured at the end of the 5-s pulse to the indicated V t . E, voltage dependence of current activation Control: V 1/2 ϭ Ϫ81 mV, k ϭ 6.48 mV; 1 mM NFA: V 1/2 ϭ Ϫ108 mV; k ϭ 6.58 mV. All data are from the same oocyte.
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at ASPET Journals on June 9, 2017 molpharm.aspetjournals.org during the first pulse. This marked reduction and slowed gating is the expected consequence of the negative shift in the voltage dependence of activation measured at steady-state conditions (Fig. 1) . In contrast, when channels were maintained in an open state during exposure to NFA, current was only slightly reduced (92 Ϯ 3% of control value). Thus, NFA preferentially affects channels in the closed state. The rapid onset and small reduction in current magnitude observed with the open state pulse protocol suggests that this reduction represents open channel block. In contrast, the large reduction in current and slowed activation induced by NFA when the V h was maintained at 0 mV indicates that the drug preferentially interacts with channels in the closed state to induce the negative shift in the voltage dependence of HCN2 activation.
We next determined the effect of 1 mM NFA on the voltage dependence of N-truncated HCN2 (HCN2 ntk ) channels. This construct was used because several mutant forms of this altered channel have been previously characterized (Chen et al., 2000) and these mutants are used later in this study. HCN2 ntk channel current was activated at more negative potentials than WT HCN2 but the effect of NFA was similar, causing a slowing of activation and a reduction of current measured at the end of the 5-s pulse (Fig. 3 , A-C). In addition, NFA slowed the rate of current deactivation measured at ϩ20 mV after a test pulse to Ϫ130 mV (Fig. 3C) . Also similar to WT HCN2, 1 mM NFA caused a leftward shift of the I-V relationship (Fig. 3D ) and the voltage dependence of current activation (Fig. 3E) for HCN2 ntk channels. The averaged and normalized I-V relationship determined for multiple oocytes (n ϭ 16) is plotted in Fig. 4A . The voltage dependence of current activation, normalized to I max for each oocyte is plotted in Fig. 4B . The average V 1/2 of WT HCN ntk channels under control conditions was Ϫ77.6 Ϯ 0.9 mV. In the presence of 1 mM NFA, the V 1/2 was Ϫ102.0 Ϯ 1.2, an average shift of Ϫ24.5 Ϯ 1.2 (n ϭ 16). The slope factor (k) for the relationship (7.5 Ϯ 0.2 mV) was not significantly altered by NFA (k ϭ 7.7 Ϯ 0.2 mV). Extrapolation of the curves from the Boltzmann fits to more negative potentials was used to estimate that 1 mM NFA reduced the maximum conductance of HCN2 ntk channel current by 22%. This reduction in current amplitude was in addition to that caused by the leftward shift in the voltage dependence of current activation. The reduction in current amplitude could be related to changes in channel gating; however, a similar reduction in current was also observed for Y331D HCN2 channels that are constitutively open and do not exhibit any time-dependent gating (Chen et al., 2001) . Current recorded at Ϫ100 mV for this mutant channel was reduced by 28 Ϯ 2% (n ϭ 8, not shown). Thus, the reduction in current induced by 1 mM NFA is probably caused by occlusion of the pore and results from drug binding to a receptor site distinct from the site that mediates altered channel gating.
The effect of NFA on the voltage dependence of HCN2 ntk channel activation was concentration-dependent. The shift in V 1/2 for activation was determined at four concentrations, ranging from 0.1 to 3 mM (Fig. 4C) . The EC 50 for this effect was 542 Ϯ 68 M (n H ϭ 0.97). The maximum NFA-induced Fig. 4 . NFA causes concentration-dependent shift in the voltage dependence of WT HCN ntk channel activation. A, normalized I-V relationships recorded before and after treatment of oocytes to 1 mM NFA (n ϭ 16). For most data points, the small S.E. bars are masked by the larger symbols. B, effect of 1 mM NFA on normalized voltage dependence of current activation (G-V relationship). The V 1/2 of WT HCN ntk channels was Ϫ77.6 Ϯ 0.9 mV and slope factor, k was 7.5 Ϯ 0.2 mV; after treatment with 1 mM NFA, V 1/2 was Ϫ102.0 Ϯ 1.2 mV and k was 7.7 Ϯ 0.2 mV (n ϭ 16). The dotted curve represents NFA data normalized to its own peak value. C, [NFA]-dependent shift in voltage dependence of HCN2 ntk channel activation. The EC 50 for the NFA-induced shift in V 1/2 was 542 Ϯ 68 M (n H ϭ 0.97).
The maximum shift in V 1/2 predicted by extrapolation of the Hill plot was Ϫ38 mV. D, kinetics of activation. Plotted data represent the average fast (open symbols) and slow (filled symbols) time constants for the onset of current activation during 5-s pulses at the indicated V t . ‫ء‬p Ͻ 0.01 compared with matched control.
1214
Cheng and Sanguinetti at ASPET Journals on June 9, 2017 molpharm.aspetjournals.org Downloaded from shift in V 1/2 predicted by extrapolation of the Hill plot was Ϫ38 mV. NFA slowed the rate of current activation, measured as fast and slow time constants, at a V t of Ϫ110 to Ϫ130 mV but decreased the fast time constant for activation at Ϫ90 mV (Fig. 4D) .
Neutralization of Single Basic Residues in Outer S4 Domain Does Not Prevent NFA-Induced Shift in Activation of HCN ntk Channels. The S4 domain of HCN2 channels has nine basic residues (Fig. 5A) , and it has been proposed (Chen et al., 2000) that the four outermost (Nterminal) basic residues are located outside the membrane when the channel is either in a closed or open state. Neutralization of one or more of these charged residues causes a graded shift in the voltage dependence of activation to more negative potentials (Chen et al., 2000; Vaca et al., 2000) , similar to the effect of NFA. We hypothesized that perhaps the acidic group of NFA might interact with one or more of these basic residues to mimic charge neutralization and hence, also cause channels to activate at more negative potentials. Therefore, we neutralized each of these residues (Lys291, Arg294, Arg297, or Arg300) by mutating it to a Gln and determined whether this altered the response of the mutant channel to 1 mM NFA. In addition, Lys291 was also mutated to a Glu, causing a reversal in charge at this position in the S4 domain. As previously reported, the mutations altered the V 1/2 and slope factor of the activation curves, but none of the single mutations prevented the negative shift in the voltage dependence of activation caused by NFA (Fig. 5,  Table 1 ). A notable exception was the K291Q mutation. NFA shifted the V 1/2 for K291Q HCN2 ntk channels the least, by only Ϫ15.3 Ϯ 1.0 mV (n ϭ 4). This difference is of doubtful significance because charge reversal at this position (K291E) responded to NFA in the usual manner with a shift in V 1/2 of Ϫ24.3 Ϯ 1.7 mV (n ϭ 5). In addition, NFA reduced the magnitude of whole cell current by ϳ20 to 30% in oocytes expressing any of the channels harboring a single S4 mutation as estimated by extrapolation of the Boltzmann fitted curves to more negative potentials (Fig. 5) . However, unlike WT HCN2 or HCN2 ntk channels, NFA caused only minor effects on the kinetics of current activation over the range of potentials examined (Fig. 6) . Table 1 .
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Neutralization of Multiple Basic Residues in Outer S4 Domain Prevents NFA-Induced Shift in Activation of HCN ntk Channels. We next determined the effects of NFA on HCN2 ntk channels with all four of the outermost basic residues neutralized by mutation to Gln (K291Q/ R294Q/R297Q/R300Q). As reported previously (Chen et al., 2000) , this "quadruple" mutant channel activated more rapidly and at more negative potentials than WT HCN2 channels. In contrast to WT HCN2 channels, 1 mM NFA only slightly slowed the kinetics of activation or deactivation of the quadruple mutant channel (Fig. 7, A and B) . The voltage dependence of current activation was determined in two groups of oocytes. In the first group (n ϭ 4), currents were activated with 1-s test pulses. NFA at 1 mM caused a slight rightward shift (ϩ6.4 Ϯ 1.0 mV) in the voltage dependence of activation and a reduction in maximum conductance of 14% (Fig. 7C) . A second group of oocytes (n ϭ 9) was activated using the usual 5-s test pulses and a similar rightward shift in V 1/2 (ϩ6.8 Ϯ 1.3 mV) was observed, along with a reduction in maximal conductance of 18% (Fig. 7D) . Thus, unlike WT channels or those harboring a single S4 mutation, neutralization of all four of the outer basic residues in the S4 domain induced a positive shift in the voltage dependence of activation.
Because single mutations did not prevent the negative shift in activation induced by NFA, whereas the quadruple mutant caused a slight shift in the opposite direction, we reasoned that NFA requires interaction with more than one basic residue in the outer region of S4 to exert its effect on channel gating. To explore this possibility, mutant channels containing neutralization of three of the four basic residues were constructed. Four different mutant channels were prepared and characterized: Lys291/Arg294/ Arg297 (Fig. 8) , Arg294/Arg297/Arg300 (Fig. 9) , Lys291/ Arg294/Arg300, and Lys291/Arg297/Arg300 (not shown). Similar to the quadruple mutant channel, these triple mutant channels were also relatively insensitive to NFAinduced changes in gating, but a reduction in current amplitude, presumably caused by channel block, was still observed. Lys291/Arg294/Arg300 and Lys291/Arg297/ Arg300 HCN2ntk channel activation was shifted to more positive potentials by NFA. A summary of the NFA-induced shifts in V 1/2 for activation of WT and mutant HCN2 ntk channels is provided in Fig. 10 .
Discussion
Fenamates possess a complicated pharmacology, affecting a number of enzymes and ion channels. NFA in particular has been subjected to intense scrutiny and either blocks and/or activates seemingly any channel chosen for investigation. Despite the amount of attention devoted to the mechanisms of action of NFA and other fenamates, the molecular basis of NFA binding to ion channels remains a mystery. The most thorough mechanistic studies have been performed by Camerino and colleagues (Liantonio et al., 2006 (Liantonio et al., , 2008 Picollo et al., 2007) and concern the modulation of ClC-K Cl Ϫ channels by NFA and other fenamates. NFA binds to two different receptor sites on ClC-Ka channels. At low concentrations (50Ϫ500 M), NFA is an activator, but higher concentrations (1Ϫ2 mM) block these channels (Liantonio et al., 2006) . In contrast, other fenamates such as flufenamic acid only block ClC-Ka currents. Modeling predicts that when only one site 
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Cheng and Sanguinetti at ASPET Journals on June 9, 2017 molpharm.aspetjournals.org is occupied, NFA increases ClC-Ka currents, whereas the occupation of both binding sites leads to channel block (Picollo et al., 2007) . Evaluation of the sensitivity of ClC-Ka to derivatives of NFA and flufenamic acid suggests that the major feature of activating compounds is the coplanarity of the two rings of the molecules, whereas block is favored when the fenamate assumes a noncoplanar configuration (Liantonio et al., 2006; Liantonio et al., 2008) . It is likely that NFA also binds to two distinct receptors on HCN2 channels Ϫ one resulting in a shift in the voltage dependence of gating, the other causing channel block.
For all channels types that have been investigated, the onset of block or altered gating induced by NFA is very rapid, consistent with its binding to a site readily accessible from the extracellular side of the membrane. However, a specific binding site for NFA or other fenamates has not been identified for any channel. We recently reported that 1 mM NFA shifts the half-point for activation of ERG1 and ERG2 channels by Ϫ6 and Ϫ18 mV, respectively. This channel subtypespecific activity was explored with chimeric channels and site-directed mutagenesis. The sensitivity of ERG1 channels to NFA could be increased to match ERG2 by swapping of their S3-S4 linker domains, equivalent to a point mutation (Gly to Arg) plus the addition of three Thr residues into ERG1. However, we did not identify mutations that could eliminate the sensitivity of ERG channels to NFA. In the present study, we found that the effects of NFA on HCN2 channels could be abrogated by mutation of multiple charged residues located in the extracellular region of S4.
Despite a similar overall molecular topology, the voltage dependence of HCN channel gating is opposite to that of Kv channels. HCN channels are closed at depolarized potentials and open in response to hyperpolarization of the membrane. Activation of the sea urchin sperm pacemaker channel is associated with inward gating currents (Mä nnikkö et al., 2002) , consistent with an inward movement of the putative voltage sensing S4 domain that was confirmed by substituted cysteine accessibility mutagenesis experiments in sea urchin sperm pacemaker and MVP, an archeabacterial HCN-like channel (Sesti et al., 2003) . Each S4 domain of an HCN channel has nine basic residues (Arg or Lys) and a single Ser residue that are located in every third position of the ␣-helix. The Ser residue is located near the middle of S4, separating the charged amino acids into an outer (N-terminal) group of five, and an inner (C-terminal) group of four basic residues (Fig. 5A) . In HCN1 channels, substituted cysteine accessibility mutagenesis analysis revealed that all five basic residues in the outer group were accessible to the Cys-modifying reagent MTSET regardless of membrane potential (Bell et al., 2004; Vemana et al., 2004) . Only residues located in the inner group changed accessibility with a change in voltage. In addition, neutralization of each of the four outer charged residues in HCN2 causes a cumulative hyperpolarizing shift in the voltage dependence of activation (Chen et al., 2000; Vaca et al., 2000) . Interestingly, mutation of the four basic residues in the outer half of S4 have only minor effects on the kinetics of current activation (Vaca et al., 2000) . Neutralization of all four charges caused a shift that was equal to the sum of the individual shifts (Vaca et al., 2000) , suggesting that the outer charged residues screen negative surface charge (Chen et al., 2000) and allow the channel to open at more physiological voltages (Mä nnikkö et al., 2002) . Taken together, these studies suggest that compared with Kv channels, the S4 domain in HCN channels may undergo a minor translocation in response to changes in transmembrane voltage (Bell et al., 2004; Vemana et al., 2004) , and that the outer four charged residues of S4 are always accessible from the extracellular space. Similar to the effects of neutralizing some of the positively charged residues in S4, NFA shifts the voltage dependence of HCN2 activation to more negative potentials. NFA exerts this effect from the extracellular side of the membrane, leading to our hypothesis that the acidic drug might shift activation by interaction with one or more basic charge in the outer S4. Although neutralization of the single outermost Lys or any one of the next three Arg failed to blunt the gating effects of NFA, we found that combined mutations prevented the negative shift in V 1/2 for activation. In addition, for some of the triple mutant channels, NFA caused a slight positive shift in V 1/2 . Finally, HCN2 channels were modified in a state-dependent manner. Drug effects were marked when the oocyte was clamped to 0 mV, but minimal when clamped to Ϫ100 mV, indicating that NFA requires interaction with channels in the closed state to exert its effects on gating. This finding is consistent with the idea that the extracellular binding site for NFA that mediates altered gating is inaccessible at negative membrane potentials because the S4 is retracted inward. However, although membrane hyperpolarization induces an inward movement of the S4 voltage sensor in sperm HCN channels as assessed by intramembrane charge displacement (Mä nnikkö et al., 2002) , membrane hyperpolarization does not alter the methanethiosulfonate ethyltrimethylammonium accessibility of the outer four basic residues in the S4 domain oh HCN1 channels (Bell et al., 2004 ). An alternative mechanism to explain the state-dependent effects of NFA is that outer region of the S4 domain undergoes a voltage-dependent rearrangement in response to hyperpolarization that disfavors the binding of NFA but does not alter interaction of methanethiosulfonate ethyltrimethylammonium with a single introduced Cys residue. The small decrease in current magnitude that was observed when NFA was applied to cells held at Ϫ100 mV is consistent with open channel block, presumably mediated by drug binding to the outer region of the pore. In summary, our findings suggest, but do not prove, that NFA directly interacts with outer S4 residues in HCN2. Radiolabeled binding studies could possibly resolve this issue; however, the very low potency of NFA (EC 50 Ϸ 0.5 mM) suggests that specific binding would be difficult to differentiate from nonspecific background binding. The slowed activation of WT HCN2 and HCN2 ntk channels induced by NFA can be largely accounted for by the negative shift in the voltage dependence of channel activation. However, for some mutant channels (i.e., R297Q, R294Q, or K291E channels; Fig. 6 ), NFA shifted the voltage dependence of gating with no apparent effect or only a limited shift in the kinetics of activation. Some of this discrepancy might be due to the multiple activities of NFA in oocytes. NFA blocks an endogenous, hyperpolarization-activated Ca 2ϩ -activated Cl Ϫ channels in oocytes (White and Aylwin, 1990) . Because the expression level of these channels varies considerably from one batch of oocytes to the next, the altered kinetics of HCN2 may result in part from block of endogenous Cl Ϫ channels rather than a direct effect on HCN2 channel gating.
Blockers of cardiac pacemaker channels have been sought for treatment of disorders where a decrease in heart rate would be beneficial. For example, slower heart rates can help alleviate symptoms in angina pectoris or other forms of myocardial ischemia by reducing the metabolic requirement of cardiac muscle. I f blockers such as ivabradine have been proposed for treating angina pectoris (Monnet et al., 2001; Vilaine, 2006) and may offer certain advantages over existing therapies. For example, both propranolol and ivabradine reduce exercise-induced ST segment shift in ischemia, but ivabradine preserved systolic shortening to a significantly greater degree than propranolol (Vilaine et al., 2003) . Three i f blocking drugs have been well characterized in native myocytes, and all exhibit kinetics consistent with gating-dependent interaction of drug with their receptor site. UL-FS49, ZD7288, and ivabradine decrease i f in a voltage-and usedependent manner consistent with preferential open-state channel block and access a binding site from the cytosolic side of the membrane (Bucchi et al., 2002) . For all three drugs, channels must open before block can occur, and membrane hyperpolarization favors unblocking. Trapping of drug inside the channel by closure of the activation gate has been demonstrated for ZD7288 (Shin et al., 2001 ). NFA and related compounds represent a different mechanistic approach toward reduction of i f in the heart. NFA reduces i f magnitude primarily by a shift in gating with only a minor reduction due to a reduction in maximal conductance, presumed to result from direct block. In native cells, 0.1 mM NFA was reported to have no effect on the maximal conductance of i f or i h . At a 10 times higher concentration, we found that NFA reduced maximal conductance of HCN2 channels by 20 to 40%. It is unknown whether a drug that modifies HCN channel gating would confer any therapeutic advantage over a pore blocker.
However, the effects of a gating modifier could be self-limiting. At high concentrations, a pore blocker can completely abolish channel current, whereas the maximal effect of a gating modifier would be limited to that caused by its maximum shift in activation (e.g., Ϫ38 mV for NFA). Discovery of a gating modifier that is more potent and channel-specific than NFA will be required before a meaningful comparison between the beneficial effects of a gating modifier and a pore blocker can be tested experimentally in animal models of myocardial ischemia. 
